How have HTGMQ shares performed in 2023?

HTG Molecular Diagnostics' stock was trading at $0.4412 on January 1st, 2023. Since then, HTGMQ shares have decreased by 99.7% and is now trading at $0.0013. View the best growth stocks for 2023 here .

How do I buy shares of HTG Molecular Diagnostics?

Shares of HTGMQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

HTG Molecular Diagnostics Stock Price, News & Analysis (NASDAQ:HTGMQ)

$0.0013

0.00 (0.00%)

(As of 12/6/2023 ET)

Compare

Today's Range: $0.0013
▼
$0.0013
50-Day Range: $0.00
▼
$0.37
52-Week Range: $0.00
▼
$23.64

Volume: 1,008 shs
Average Volume: 244,682 shs
Market Capitalization: $2,873.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Earnings Financials SEC Filings Social Media

About HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

HTGMQ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HTGMQ Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive HTGMQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HTG Molecular Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 12/06/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Analytical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:HTGMQ
CUSIP: N/A
CIK: 1169987
Web: www.htgmolecular.com
Phone: 877-289-2615
Fax: 520-547-2837
Employees: 53
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-21,590,000.00
Net Margins: -324.25%
Pretax Margin: -324.05%
Return on Equity: 45.52%
Return on Assets: 8.93%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.40
Quick Ratio: 1.30

Sales & Book Value

Annual Sales: $6.37 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.44 per share
Price / Book: 0.00

Miscellaneous

Outstanding Shares: 2,210,000
Free Float: 2,156,000
Market Cap: $2,873.00
Optionable: Not Optionable
Beta: 3.05

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. John L. Lubniewski (Age 59)
President, CEO & Director
Comp: $821.19k
Mr. Shaun D. McMeans (Age 61)
Senior VP, CFO, Secretary & Treasurer
Comp: $533.97k
Ms. Laura Lee Godlewski (Age 43)
Senior Vice President of Finance & Administration
Dr. Debra A. Gordon (Age 63)
Senior VP & Chief Legal Counsel
Comp: $219.47k
Dr. Patrick C. Roche (Age 70)
Senior Vice President of Research & Development
Comp: $257.58k
Dr. Stephen A. Barat Ph.D. (Age 53)
Senior Vice President of Therapeutics
Dr. Christina M. Carruthers Ph.D.
Vice President of Target Strategy & Early Development
Debrah Thompson
Vice President of Scientific Innovation

Key Competitors

View All Competitors

HTGMQ Stock Analysis - Frequently Asked Questions

How have HTGMQ shares performed in 2023?: HTG Molecular Diagnostics' stock was trading at $0.4412 on January 1st, 2023. Since then, HTGMQ shares have decreased by 99.7% and is now trading at $0.0013.
View the best growth stocks for 2023 here.
How do I buy shares of HTG Molecular Diagnostics?: Shares of HTGMQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:HTGMQ) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial